Morton Brown Family Wealth, LLC Iovance Biotherapeutics, Inc. Transaction History
Morton Brown Family Wealth, LLC
- $287 Million
- Q4 2024
A detailed history of Morton Brown Family Wealth, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Morton Brown Family Wealth, LLC holds 49 shares of IOVA stock, worth $272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49
Previous 49
-0.0%
Holding current value
$272
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
341Shares Held
248MCall Options Held
4.04MPut Options Held
3.1M-
Vanguard Group Inc Valley Forge, PA27.5MShares$153 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$136 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$123 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$118 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$68.2 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $879M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...